BOSTON, April 16, 2019 /PRNewswire/ -- Parabricks Inc. (www.parabricks.com), announced today their collaboration with Google Cloud as a Technology Partner, launching their accelerated, deep learning based product suite for primary and secondary analysis of sequencing data. Now available on the Google Cloud Platform (GCP) Marketplace, Parabricks reduces the time and cost required to go from raw sequencing data to variants for a whole genome, producing variant calls in less than an hour compared to the standard 30 hours when running the same industry standard pipeline on HPC CPU clusters. The Parabricks enterprise-grade analysis suite provides push-button operation, 100% reproducibility and containerization of the latest secondary analysis tools used by bioinformaticians worldwide. Currently, Parabricks supports the full GATK4 germline, somatic and variant calling pipelines, DeepVariant and population study tools.
The company introduced its solution on the GCP Marketplace at Bio-IT World with a presentation at the Google Cloud booth. "We are excited to announce a relationship that will bring the cost and performance benefits of Parabricks' GPU-optimized analytics to Google Cloud Platform," said Dr. Ankit Sethia, CTO of Parabricks Inc. "By incorporating the latest and greatest from accelerated GPU computing and deep learning, we can provide 30-50 times faster analysis at lower costs while generating results that are equivalent to the established industry-standard tools."
"The Parabricks solution is widely used in in-house clusters and with the growing adoption of cloud computing in genomics, it was important for us to provide an easy to use cloud solution. Google Cloud Platform has a strong user base in the genomics market and our solution can greatly benefit that base," said Dr. Mehrzad Samadi, CEO of Parabricks Inc. "Users will get the exact same results at either the same or lower cost in less than an hour instead of having to wait for more than a day for their results. This kind of performance is critical for both clinical settings where patient treatment decisions need to be made in a timely fashion, along with large scale population studies where tens of thousands of genomes must be sequenced, analyzed and often re-analyzed to standardize the data set to one analysis. By collaborating with GCP, we are now bringing these same benefits to the cloud."
On the GCP Marketplace, the solution will be available for a limited free trial period, ending July 1st. Interested parties can email [email protected] to get a trial license. More information about the Parabricks software suite can be found on the Parabricks website.
Parabricks is based in Ann Arbor, Michigan and provides high performance GPU-based software solutions for analysis of large data sets, including next generation sequencing data. The Parabricks product suite provides scientists high throughput analysis pipelines at reduced costs compared to other available solutions—in the cloud or on-premise. Parabricks brings proprietary high performance computing techniques to accelerate the data analysis process of the state-of-the-art GATK4 pipeline, reducing the analysis time from days to less than one hour while also reducing the cost by up to 75%–all while generating fully equivalent and accurate output. Parabricks software can integrate seamlessly with state-of-the-art deep learning techniques, statistical packages, and visualization tools; enabling users to focus on extracting insights from data. For more information, please visit www.parabricks.com or contact Parabricks at [email protected].